Search Results - "Żuber, Zbigniew"
-
1
Oligoarticular onset juvenile idiopathic arthritis as the most common cause of disability of children and young adults
Published in Reumatologia (2019)Get full text
Journal Article -
2
Comment on the article "Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology"
Published in Reumatologia (2018)“…Extensive team work is in my opinion an excellent presentation of current knowledge about the new drug, actually a new group of small-molecule targeted DMARDs…”
Get full text
Journal Article -
3
Diagnostic Value of Whole-Body MRI in Pediatric Patients with Suspected Rheumatic Diseases
Published in Medicina (Kaunas, Lithuania) (28-08-2024)“…: The diagnosis of rheumatic diseases in children is challenging and requires the use of advanced imaging examinations such as whole-body magnetic resonance…”
Get full text
Journal Article -
4
Role of Microparticles in the Pathogenesis of Inflammatory Joint Diseases
Published in International journal of molecular sciences (01-11-2019)“…Rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA) make up a group of chronic…”
Get full text
Journal Article -
5
Role of Distinct Macrophage Populations in the Development of Heart Failure in Macrophage Activation Syndrome
Published in International journal of molecular sciences (23-02-2022)“…Macrophage activation syndrome (MAS) is one of the few entities in rheumatology with the potential to quickly cause multiple organ failure and loss of life,…”
Get full text
Journal Article -
6
Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis
Published in Journal of clinical medicine (08-09-2019)“…Principles of treat-to-target (T2T) have been widely adopted in both multinational and regional guidelines for rheumatoid arthritis (RA). Several questionnaire…”
Get full text
Journal Article -
7
Access to biologics and Janus kinase inhibitors for treatment of rheumatic diseases in the biosimilars era in Poland: a nation-level study
Published in Polskie archiwum medycyny wewne̦trznej (26-04-2024)“…By reducing treatment costs, biosimilars provide an opportunity to improve accessibility to highly effective drugs. This study aimed to evaluate access to…”
Get more information
Journal Article -
8
Coexisting Sacroiliac Arthritis and Chronic Nonbacterial Osteomyelitis in an Adolescent with Ehlers-Danlos Syndrome: A Case Report and Treatment Success
Published in The American journal of case reports (22-09-2024)“…BACKGROUND Chronic nonbacterial osteomyelitis (CNO) is a multifocal autoinflammatory bone disease mainly affecting children and adolescents. Sacroiliitis is an…”
Get full text
Journal Article -
9
Magnetic resonance imaging of the musculoskeletal system in the diagnosis of rheumatic diseases in the pediatric population
Published in Reumatologia (01-01-2024)“…Magnetic resonance imaging (MRI) of the musculoskeletal system is an examination increasingly performed for suspected juvenile idiopathic arthritis, chronic…”
Get full text
Journal Article -
10
Vaccinations in Selected Immune-Related Diseases Treated with Biological Drugs and JAK Inhibitors-Literature Review and Statement of Experts from Polish Dermatological Society
Published in Vaccines (Basel) (01-01-2024)“…The growing use of biological drugs in immune-mediated chronic diseases has undoubtedly revolutionized their treatment. Yet, the topic of vaccinations in this…”
Get full text
Journal Article -
11
Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland
Published in Biomedicines (01-06-2023)“…Mucopolysaccharidosis type II (MPS II; also known as Hunter syndrome) is a rare, inherited lysosomal storage disease. The disease is caused by deficiency of…”
Get full text
Journal Article -
12
Antibodies Recognizing Yersinia enterocolitica Lipopolysaccharides of Various Chemotypes in Synovial Fluids From Patients With Juvenile Idiopathic Arthritis
Published in Journal of immunology research (2022)“…Yersinia enterocolitica O:3 (YeO3) is considered to be associated with reactive arthritis (ReA), and its lipopolysaccharide (LPS) has been detected in synovial…”
Get full text
Journal Article -
13
Deep dive into achieving the therapeutic target: results from a prospective, 6‑month, observational study nested in routine rheumatoid arthritis care
Published in Polskie archiwum medycyny wewne̦trznej (26-09-2022)“…Achieving remission or lowdisease activity (LDA) is an integral principle of treat‑to‑target (T2T) strategy in rheumatoid arthritis (RA). Prior studies have…”
Get more information
Journal Article -
14
Ultrasound Evaluation of the Effectiveness of the Use of Acitretin in the Treatment of Nail Psoriasis
Published in Journal of clinical medicine (14-05-2021)“…The study aimed to evaluate the effect of retinoid treatment on the morphological changes in the nail apparatus in patients with nail psoriasis. Material and…”
Get full text
Journal Article -
15
COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion
Published in Reumatologia (01-01-2024)“…As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, infection management in vulnerable populations requires formalized guidance. Although…”
Get full text
Journal Article -
16
Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care
Published in Journal of clinical medicine (11-09-2021)“…Introduction: Real-world data indicate disparities in biologic access across Europe. Objectives: To describe the national structure of PsA care in Poland, with…”
Get full text
Journal Article -
17
The effect of recombinant human iduronate-2-sulfatase (Idursulfase) on growth in young patients with mucopolysaccharidosis type II
Published in PloS one (13-01-2014)“…Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked, recessive, lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase…”
Get full text
Journal Article -
18
Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
Published in Clinical rheumatology (01-07-2018)“…Efficacy and safety of tocilizumab (TCZ), an interleukin-6 receptor inhibitor, were demonstrated in juvenile idiopathic arthritis (JIA) with polyarticular…”
Get full text
Journal Article -
19
Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment
Published in Reumatologia (01-01-2023)“…Rheumatoid arthritis (RA) is a risk factor (RF) for cardiovascular (CV) disease, a leading cause of mortality in RA patients. Consecutive records of RA…”
Get full text
Journal Article -
20
A case of mucopolysaccharidosis type VI in a polish family. Importance of genetic testing and genotype-phenotype relationship in the diagnosis of mucopolysaccharidosis
Published in Molecular genetics and metabolism reports (01-12-2020)“…Mucopolysaccharidosis type VI (MPS VI) is a rare, autosomal recessive lysosomal storage disorder caused by deficient enzymatic activity of N-acetyl…”
Get full text
Journal Article